BDBM50406322 CHEMBL5267385::US20240190892, Example 43

SMILES CN1CCN(CC1)c1ccc(CNC(=O)c2cncc(n2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cn1

InChI Key InChIKey=DCERKBJMFDNXOI-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50406322   

TargetPlasma kallikrein(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50406322(CHEMBL5267385 | US20240190892, Example 43)
Affinity DataIC50: 1.70nMAssay Description:Inhibition of human plasma kallikrein using Acetyl-K- P-R-AFC as substrate by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetPlasma kallikrein(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50406322(CHEMBL5267385 | US20240190892, Example 43)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human factor 11a using GPR-AFC as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins by fluor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetPlasma kallikrein(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50406322(CHEMBL5267385 | US20240190892, Example 43)
Affinity DataIC50: 1.70nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of plasma kallikrein can be determined using a relevant purified serine prot...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50406322(CHEMBL5267385 | US20240190892, Example 43)
Affinity DataIC50: 1.00E+4nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation factor XIa can be determined using a relevant purified serine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent